StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.80−0.01 (-0.86%)

Close on Nov 16, 2026Market cap $103.34MP/E –Yield –

Organogenesis profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Organogenesis's profit margin for the twelve months ending Jun 30, 2026 was -18.4%. For fiscal 2025 it was 6.6%, against 0.2% the year before. The highest annual figure on record is 20.2% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20256.6%+6.4
FY2024Dec 31, 20240.2%−1.0
FY2023Dec 31, 20231.1%−2.3
FY2022Dec 31, 20223.4%−16.7
FY2021Dec 31, 202120.2%+15.1
FY2020Dec 31, 20205.1%+19.9
FY2019Dec 31, 2019-14.8%+18.7
FY2018Dec 31, 2018-33.5%−29.3
FY2017Dec 31, 2017-4.2%+8.0
FY2016Dec 31, 2016-12.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-220.0%−210.7
Q1 FY2026Mar 31, 2026-142.8%−121.0
Q4 FY2025Dec 31, 202519.4%+13.3
Q3 FY2025Sep 30, 202514.3%+3.6
Q2 FY2025Jun 30, 2025-9.3%+3.8
Q1 FY2025Mar 31, 2025-21.7%−19.8
Q4 FY2024Dec 31, 20246.1%+6.6
Q3 FY2024Sep 30, 202410.7%+7.8
Q2 FY2024Jun 30, 2024-13.1%−17.6
Q1 FY2024Mar 31, 2024-1.9%+0.8
Q4 FY2023Dec 31, 2023-0.6%−7.1
Q3 FY2023Sep 30, 20232.9%+2.7
Q2 FY2023Jun 30, 20234.5%−2.7
Q1 FY2023Mar 31, 2023-2.8%−1.8
Q4 FY2022Dec 31, 20226.5%−33.4
Q3 FY2022Sep 30, 20220.2%−10.9
Q2 FY2022Jun 30, 20227.2%−9.6
Q1 FY2022Mar 31, 2022-0.9%−10.6
Q4 FY2021Dec 31, 202139.9%+22.7
Q3 FY2021Sep 30, 202111.1%−9.5
Q2 FY2021Jun 30, 202116.8%+24.3
Q1 FY2021Mar 31, 20219.7%+36.1
Q4 FY2020Dec 31, 202017.1%+20.7
Q3 FY2020Sep 30, 202020.6%+37.3
Q2 FY2020Jun 30, 2020-7.5%+7.4
Q1 FY2020Mar 31, 2020-26.4%+1.0
Q4 FY2019Dec 31, 2019-3.6%+11.0
Q3 FY2019Sep 30, 2019-16.7%+9.0
Q2 FY2019Jun 30, 2019-14.9%+31.1
Q1 FY2019Mar 31, 2019-27.4%+35.9
Q4 FY2018Dec 31, 2018-14.6%−6.2
Q3 FY2018Sep 30, 2018-25.8%−15.3
Q2 FY2018Jun 30, 2018-45.9%−46.0
Q1 FY2018Mar 31, 2018-63.3%−69.0
Q4 FY2017Dec 31, 2017-8.3%−8.2
Q3 FY2017Sep 30, 2017-10.5%–
Q2 FY2017Jun 30, 20170.1%–
Q1 FY2017Mar 31, 20175.7%–
Q4 FY2016Dec 31, 2016-0.1%–

More Organogenesis figures

See a number that looks wrong?